FMS News & Events

Fresenius Medical Care announced the launch of the first tranche of its new share buyback program with a total volume of around EUR 1B. The first tranche, amounting up to EUR 600M, was initiated May 28 and is expected to be completed by December 15, 2026.

Fresenius Medical Care intends to execute a new share buyback program with a total volume of around EUR 1B. The program shall be executed in tranches over a period of 12 months from its start. It is expected to begin in the near future and only a few weeks after the previous share buyback program was successfully completed on April 30.

The Supervisory Board of Fresenius Medical Care has reappointed CFO and Management Board Member Martin Fischer for a period of five years until 2031.